Home
Headlines & Research Highlights
Prime Minister of Canada announces establishment of premier centre for advanced medical isotope research and development at TRIUMF
01 November 2018
TRIUMF welcomed Prime Minister Trudeau for a special visit where he announced investments to support a new state-of-the art life sciences facility, the Institute for Advanced Medical Isotopes (IAMI)
TRIUMF launches new Five-Year Plan 2020-2025
09 October 2018
Designed to maximize impact, build on existing strengths, and capitalize on emerging opportunities, TRIUMF’s Five-Year Plan 2020-2025 lays out a vision for Canada’s particle accelerator centre for the next five years and the decades beyond
TRIUMF hyped by major neutrino project announcement
02 October 2018
Neutrino physics researchers at TRIUMF and around the world welcome new signals of support for planned Hyper-K detector
TRIUMF and CNL to form strategic partnership to enable ground-breaking cancer treatment
27 September 2018
Leading Canadian laboratories collaborate to produce Actinium-225, a rare medical isotope with the potential to revolutionize the fight against untreatable forms of cancer
New documentary highlights TRIUMF’s role in producing promising radioisotope for cancer treatment
12 September 2018
A new short documentary, The Rarest Drug on Earth, is delving into the possibility for TRIUMF to take up the reins as the world’s largest producer of actinium-225.
